News
Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a ...
Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...
Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results